Comparison of Treatment Patterns in Patients with Migraine Initiating Calcitonin Gene-Related Peptide Monoclonal Antibodies: A Retrospective Real-World US Study.
Oralee J VarnadoBrenna L BradyAnthony J ZagarYvonne P RoblesMargaret Hoyt
Published in: Patient preference and adherence (2024)
Patients with migraine who initiated treatment with galcanezumab showed higher persistence and lower treatment discontinuation rates than those initiating either fremanezumab or erenumab.